AU5439890A - A method of reducing body weight and food intake using a dopamine d2 receptor agonist - Google Patents

A method of reducing body weight and food intake using a dopamine d2 receptor agonist

Info

Publication number
AU5439890A
AU5439890A AU54398/90A AU5439890A AU5439890A AU 5439890 A AU5439890 A AU 5439890A AU 54398/90 A AU54398/90 A AU 54398/90A AU 5439890 A AU5439890 A AU 5439890A AU 5439890 A AU5439890 A AU 5439890A
Authority
AU
Australia
Prior art keywords
dopamine
body weight
receptor agonist
food intake
reducing body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54398/90A
Other languages
English (en)
Inventor
James D. Belluzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitby Research Inc
Original Assignee
Whitby Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitby Research Inc filed Critical Whitby Research Inc
Publication of AU5439890A publication Critical patent/AU5439890A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU54398/90A 1989-05-09 1990-04-19 A method of reducing body weight and food intake using a dopamine d2 receptor agonist Abandoned AU5439890A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34909189A 1989-05-09 1989-05-09
US349091 1989-05-09

Publications (1)

Publication Number Publication Date
AU5439890A true AU5439890A (en) 1990-11-29

Family

ID=23370872

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54398/90A Abandoned AU5439890A (en) 1989-05-09 1990-04-19 A method of reducing body weight and food intake using a dopamine d2 receptor agonist

Country Status (3)

Country Link
EP (1) EP0483152A4 (fr)
AU (1) AU5439890A (fr)
WO (1) WO1990013294A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
CA2483464C (fr) 2002-05-17 2011-12-20 Duke University Procede de traitement de l'obesite
MXPA05011557A (es) 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
BRPI0506829A (pt) 2004-01-13 2007-05-29 Univ Duke composições de anticonvulsivo e droga antipsicótica e métodos para sua utilização para afetar perda de peso
CA2630624C (fr) 2005-11-22 2013-08-06 Orexigen Therapeutics, Inc. Compositions et procedes d'augmentation de la sensibilite a l'insuline
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20180066272A (ko) 2006-11-09 2018-06-18 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
CA2725930A1 (fr) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Procedes pour traiter des pathologies des graisses viscerales
BRPI0920645A2 (pt) * 2008-10-13 2016-01-12 Interquim Sa processo para a preparação de compostos de (s)-(-)-2-(n-propilamino_-5- metoxitetralma e (s)-(-)-2-(n-propilamino)-5-hidroxitetralina opticamente ativos
MX344303B (es) 2010-01-11 2016-12-13 Orexigen Therapeutics Inc Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
IL300868A (en) 2012-06-06 2023-04-01 Orexigen Therapeutics Inc Methods for treating overweight and obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189494A (en) * 1975-11-06 1980-02-19 Sandoz Ltd. Reducing free fatty acid of the blood and suppressing appetite
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins

Also Published As

Publication number Publication date
EP0483152A1 (fr) 1992-05-06
WO1990013294A1 (fr) 1990-11-15
EP0483152A4 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
AU5439890A (en) A method of reducing body weight and food intake using a dopamine d2 receptor agonist
AU4145089A (en) Neck exercising device and method
AU6127790A (en) Improved sorbitol coated comestible and method of preparation
AU3061595A (en) A method for decreasing the fat content and for increasing the muscle and protein content of animals
AU4048089A (en) Insecticidal device and method of using same
ZA9410056B (en) Indoline derivatives method of preparation and use
AU4997893A (en) A novel human dopamine receptor and its uses
AU7486591A (en) Apparatus and method for providing a stall cache
AU6750594A (en) Receptors of interleukin-12 and antibodies
AU3681795A (en) Polypeptide agonists and antagonists of human interleukin-8
AU6030990A (en) Soluble human b-cell interleukin-1 receptor
AU4538689A (en) Decanter with attached spout-handle and method of making same
AU614919B2 (en) Adjustable piston-driver connection and method of adjusting
AU1242192A (en) Method and device for determining the weight of pigs
AU632851B2 (en) Substituted dibenzofurans and methods of using same
AU5024290A (en) Vibratory article coater and method
AU3119289A (en) Poultry and like feeder
AU3426989A (en) Method for making aminophenols and their amide derivatives
AU8059291A (en) Packaged chinese food and method of preparing same
AU1927195A (en) Improving growth and lactation of ruminants
CS694688A1 (en) Method of 2-(methylaminoalcoxy) biphenyls and their hydrochlorides preparation
AU1988795A (en) Antibodies to interleukin-8 receptors and methods of use
AU5093890A (en) Method and device for transferring of valuable documents
DK150089A (da) Solfanger med indbyggede akryllinser
CS40088A1 (en) Preparation with successive release of substance's niphedipine and method of its preparation